News
Warmly celebrate that Zhejiang Chiral has successfully passed US FDA five days inspection (from OCT.09 to OCT.13.2017) and perfectly resulted with no 483 deficiency, Which is the fourth time approved
Warmly celebrate that Zhejiang Chiral has successfully passed US FDA five days inspection (from OCT.09 to OCT.13.2017) and perfectly resulted with no 483 deficiency, Which is the fourth time approved by US FDA. (Gabapentin, Etodolac, Carbidopa).
